Technology | March 17, 2010

Colon Cancer Test Offers Alternative Diagnostic Exam

March 17, 2010 - In the State of Tennessee has one of the highest incidence rates of and mortality rates for colon cancer in the United States, and during colon cancer month, a Tennessee-based company presented state legislators with a colon cancer test that could save millions of lives and cut healthcare costs.

The colon cancer test measures a unique biomarker and a testing process utilizes ColoMarker a simple blood test. The ColoMarker test looks for a substance in blood called CA1-18. In clinical trials, in which researchers tested 2,370 blood samples, ColoMarker showed an overall accuracy rate for detecting colon cancer of 93 percent. In another early trial, researchers tested for the presence of ColoMarker in 243 blood samples from patients who had symptoms of colon cancer. They compared the results of these blood tests to results from the Fecal Occult Blood Test (FOBT). ColoMarker had a false positive rate of 11 percent compared with a false positive rate of 30 percent for FOBT.

EDP Biotech, the manufacturer of the test, says it could possibly be used on patients who otherwise would not participate in more invasive screening procedures. The company offered U.S. Legislators the opportunity to personally experience the ColoMarker test by enrolling in the control study group for EDP’s latest research.

For more information: www.edpbiotech.com

Related Content

Insurance Coverage for CT Colonography Increases Likelihood of Screening
News | Colonoscopy Systems | July 12, 2017
People with insurance policies that cover computed tomography (CT) colonography for colorectal cancer screening are...
CT colonography (CTC) allows visualization of the entire colon in one image

CT colonography (CTC) allows visualization of the entire colon in one image. Photo courtesy of Judy Yee, M.D.

Feature | Imaging | July 05, 2017 | By Jeff Zagoudis
Computed tomography colonography (CTC), also known as virtual colonoscopy, offers a noninvasive alternative to...
Technology | Colonoscopy Systems | March 27, 2017
March 27, 2017 — Bracco Diagnostics Inc. announced the launch of its PROTOCO2L TOUCH Colon Insufflator.
CT colonography, patient and provider groups, Congress, screening, H.R. 1298
News | Colonoscopy Systems | March 02, 2017
Major colorectal cancer care advocacy groups and medical societies have released a statement strongly urging Congress...
Affordable Care Act, economic disparities, mammography, colonoscopy, cancer screening
News | Business | February 08, 2017
Out-of-pocket expenditures are thought to be a significant barrier to receiving cancer preventive services, especially...
Check-Cap, C-Scan system, colorectal cancer screening, clinical trial, CE Mark
News | Colonoscopy Systems | January 31, 2017
Check-Cap Ltd. recently announced the enrollment of the first patient in its multi-center study of the C-Scan system in...
News | Colonoscopy Systems | January 26, 2017
Researchers have developed the first sensor capable of objectively identifying inflammatory bowel disease (IBD) and...
Given, Pillcamp, colonoscopy, Angiodysplasias, capsule Endoscopy, LVAD interference

The Given Imaging PillCam Colon system is an example of a capsule endoscopy device the patient swallows to image the gastrointestinal track.

Feature | Endoscopes | January 03, 2017 | Anamika Kumari
The capsule endoscopy systems offer a hands-free and highly accurate imaging modality for healthcare practitioners.
Check-Cap, colorectal cancer screening capsule, ACG, UEGW, clinical data, colorectal cancer screening
News | Colonoscopy Systems | October 27, 2016
Check-Cap Ltd. announced additional clinical data was recently presented on its ingestible capsule for preparation-free...
Overlay Init